Miftek Inc. With a focus on the micro-fluidic domain, Miftek integrates cutting-edge capabilities and innovative methods to identify cellular systems and their functions. Our ultimate goal is to create next-generation diagnostic tools.

At Miftek, we have successfully developed highly sensitive photon detection devices that are currently at the forefront of the market. We are dedicated to incorporating this breakthrough technology into various new devices. Among our notable achievements, the Miftek team holds the patent for Spectral Flow Cytometry, which we were the first to develop.

We are thrilled to announce that Miftek Corporation has been awarded an SBIR Phase I grant by the National Science Foundation. This $225,000 grant will support the further development of our groundbreaking single photon 42-channel sensor array. With its exceptional speed and minimal noise, this sensor array is set to revolutionize the market by offering unmatched sensitivity and speed.

It has the potential to significantly impact industries such as high-level microscopy and other photon-based instruments. To stay updated with our latest innovations, meet us at Photonics West in San Francisco from January 29th to 31st. Join us as we continue to push the boundaries of photon technology and shape the future of diagnostics